Tissue distribution and metabolism of the [32P]-labeled oligodeoxynucleoside methylphosphonate-neoglycopeptide conjugate, [YEE(ah-GalNAc)3]-SMCC-AET-pUmpT7, in the mouse.

Development of oligodeoxynucleotides (oligo-dNs) and their analogs as therapeutic agents is complicated by their low rate of transport across cellular membranes, which is required for interaction with the intracellular complementary nucleic acid sequences, and the lack of tissue-specific delivery. To overcome these obstacles, bioconjugates between cell surface receptor ligands and oligodeoxynucleoside methylphosphonates (oligo-MPs) have been constructed containing homogeneous, chemically defined covalent linkages. We have previously established that a model conjugate, [32P]-labeled [YEE(ah-GalNAc)3]-SMCC-AET-pUmpT7 (1), is delivered to Hep G2 cells in a ligand-specific manner, reaching a peak value of 26 pmol per 10(6) cells after 24 hours incubation at 37 degrees C (Hangeland et al., 1995). In this work, the in vivo behavior of this conjugate is explored. Administration of this conjugate to mice via tail vein injection demonstrates rapid uptake in liver to the extent of 69.9 +/- 9.9% of the injected dose after 15 minutes. Thereafter, the conjugate and its metabolites are rapidly cleared via the kidney and urine. Polyacrylamide gel electrophoresis analysis of extracts of Hep G2 cells and mouse liver reveal the conjugate 1 to be extensively metabolized. In contrast, the conjugate found in mouse urine is largely intact. These data show that this novel, biodegradable delivery vehicle represents a viable approach for the delivery of antisense oligo-MPs and other oligo-dN analogs to the liver for therapeutic and diagnostic applications.

[1]  J. Levis,et al.  Cell-type specific and ligand specific enhancement of cellular uptake of oligodeoxynucleoside methylphosphonates covalently linked with a neoglycopeptide, YEE(ah-GalNAc)3. , 1995, Bioconjugate chemistry.

[2]  M. Findeis,et al.  Targeted delivery of DNA using YEE(GalNAcAH)3, a synthetic glycopeptide ligand for the asialoglycoprotein receptor. , 1994, Bioconjugate chemistry.

[3]  K. Rice,et al.  In vivo targeting function of N-linked oligosaccharides with terminating galactose and N-acetylgalactosamine residues. , 1994, The Journal of biological chemistry.

[4]  T. V. van Berkel,et al.  Characterization of the interaction of galactose-exposing particles with rat Kupffer cells. , 1994, The Biochemical journal.

[5]  B. Calabretta,et al.  Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells. , 1994, British Journal of Cancer.

[6]  M. Yarmush,et al.  Antisense DNA delivery in vivo: liver targeting by receptor-mediated uptake. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  H. Eichler,et al.  Studies on the uptake of low molecular weight monomeric tris-galactosyl conjugates by the rat liver. , 1992, Biochemical pharmacology.

[8]  K. Zatloukal,et al.  Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. , 1992, Bioconjugate chemistry.

[9]  M. Monsigny,et al.  Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates. , 1992, Nucleic acids research.

[10]  V. Torchilin,et al.  Use of N-terminal modified poly(L-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells. , 1992, Bioconjugate chemistry.

[11]  J. Wilson,et al.  Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. , 1991, The Journal of biological chemistry.

[12]  P. Low,et al.  Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Cotten,et al.  Transferrin-polycation conjugates as carriers for DNA uptake into cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Lamond,et al.  Highly efficient chemical synthesis of 2'-O-methyloligoribonucleotides and tetrabiotinylated derivatives; novel probes that are resistant to degradation by RNA or DNA specific nucleases. , 1989, Nucleic acids research.

[15]  R. G. Anderson,et al.  Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. , 1988, The Journal of biological chemistry.

[16]  J. Slot,et al.  Immunoelectron microscopic localization of acidic intracellular compartments in hepatoma cells. , 1985, The EMBO journal.

[17]  G. Wahl,et al.  Derivatization of unprotected polynucleotides. , 1983, Nucleic acids research.

[18]  H. Kolb,et al.  Electron microscopic evidence for an asialoglycoprotein receptor on kupffer cells: Localization of lectin-mediated endocytosis , 1982, Cell.

[19]  D. Wall,et al.  The galactose-specific recognition system of mammalian liver: The route of ligand internalization in rat hepatocytes , 1980, Cell.

[20]  H. Stukenbrok,et al.  An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. II. Intracellular fates of the 125I- ligands , 1979, The Journal of cell biology.

[21]  G. Wilson,et al.  An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. I. Distribution of 125I-ligands among the liver cell types , 1979, The Journal of cell biology.

[22]  C. Steer,et al.  Unique distribution of glycoprotein receptors on parenchymal and sinusoidal cells of rat liver. , 1979, The Journal of biological chemistry.